Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
50 participants
OBSERVATIONAL
2016-11-30
2021-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Database of Tissue Samples to Understand the Inflammatory Response After Cardiac Surgery
NCT02488876
Study of the Clinical Scoring System and Cytokines for Prediction of Inflammatory Response in Major Surgery
NCT01353157
Study of the Corelation Between Circulating Nuclearsome and SIRS Happened After Congential Cardiac Surgery
NCT02325765
Post-surgery Systemic Inflammation and Neuro-immune Interactions
NCT03055325
Management Practices and the Risk of Infection Following Cardiac Surgery
NCT01089712
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients that develop SIRS
Immunophenotyping of patients that develop SIRS after heart surgery
Immunophenotyping
Multiplex assays for screening pro- and anti-inflammatory markers and RNA will be analysed using a next generation sequencing approach
Patients that develop no SIRS
Immunophenotyping of patients that develop no SIRS after heart surgery
Immunophenotyping
Multiplex assays for screening pro- and anti-inflammatory markers and RNA will be analysed using a next generation sequencing approach
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Immunophenotyping
Multiplex assays for screening pro- and anti-inflammatory markers and RNA will be analysed using a next generation sequencing approach
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Informed consent of the patient
* Patient undergoing a open heart surgery using a cardiopulmonary bypass
Exclusion Criteria
* Missing informed consent
* Renal failure
* Liver failure
* Neurodegenerative disease
* Malignancies
* Immune therapy
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Bonn
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dr. Christian Bode
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eicke Latz, MD, PhD
Role: STUDY_CHAIR
Institute of Innate Immunity
Christian Bode, MD
Role: STUDY_CHAIR
Department of Anesthesia and Critical Care Medicine
Folkert M Steinhagen, MD
Role: PRINCIPAL_INVESTIGATOR
Department of Anesthesia and Critical Care Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital Bonn
Bonn, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Related Links
Access external resources that provide additional context or updates about the study.
Related Info
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BOST-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.